MiRNA-based therapeutics for Melanoma: Tumor suppressor p53 suppresses the expression of Syndecan-1 via up regulation of its target gene, 13/April/2014, 6.06 am

Treating human cancer with a Diabetic pill: Acarbose, an anti-diabetic drug used to treat non-insulin-dependent Diabetes Mellitus, suppresses the expression of LRP-1 via up regulation of its target gene, 13/April/2014, 5.35 am
April 13, 2014
MiRNA-based therapeutics for Melanoma: Activin-A suppresses the expression of Syndecan-1 via up regulation of its target gene, 13/April/2014, 6.11 am
April 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, MiRNA-based therapeutics for Melanoma: Tumor suppressor p53 suppresses the expression of Syndecan-1 via up regulation of its target gene, 13/April/2014, 6.06 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.